Developing a new medicine is a long process that costs the pharmaceutical industry millions of euros in investment. Over ten years can pass from the start of the research phase to market launch. According to Farmaindustria data, over half of investment costs go on designing, developing and evaluating clinical trial phases 1, 2 and 3. The remainder is invested in basic research, approval processes and pharmacovigilance tasks. Only one in five medicines that are marketed generate more revenue than the cost of the R&D phase.
At Lexic we are extremely sensitive to this long and costly process and have spent 15 years helping marketing departments launch new drugs and new indications for previously marketed ones, providing a wide range of materials and services that guarantee a successful launch. We also help your sales force reach their targets by supplying translated training materials adapted to the local market where necessary.